How to get more women in the C-suite, according to IPG, Unilever, and AOL

A new report analyzing gender parity in advertising found that men tend to endorse other men at higher rates than women. Execs share their insights ...

Which drugmakers have the healthiest presence on social media?

Which drugmakers have the healthiest presence on social media?

A study of the social media activity of pharmaceutical firms finds that Lilly is the most active, but Novo Nordisk and Boehringer Ingelheim have better engagement.

Uber partners with startup to take patients to the doctor

Uber partners with startup to take patients to the doctor

A 2005 study estimated that 3.6 million people do not receive nonemergency medical care because they don't have access to transportation.

The FDA, Astellas, and Accenture use innovation competitions to help address business challenges

The FDA, Astellas, and Accenture use innovation competitions to help address business challenges

The organizations are using innovation competitions to challenge internal and external audiences with coming up with new ideas.

Five things for pharma marketers to know: Wednesday, September 28, 2016

Five things for pharma marketers to know: Wednesday, September 28, 2016

Patient advocacy groups stay silent in drug-pricing debate; Opdivo to be tested in combination with Nektar drug; 25% of FDA employees now work for industry

Five things for pharma marketers to know: Tuesday, September 27, 2016

Five things for pharma marketers to know: Tuesday, September 27, 2016

Amgen's Kyprolis fails to best Velcade in trial; diabetes drugs have lower than average FDA approval rate; Bayer's derm business draws interest

The FDA denies approval of abuse-deterrent opioid after promotional warning

The FDA denies approval of abuse-deterrent opioid after promotional warning

The agency denied Pain Therapeutics' and Durect's abuse-deterrent opioid in a complete response letter after warning the drugmakers about how they promoted the drug.

Five things for pharma marketers to know: Monday, September 26, 2016

Five things for pharma marketers to know: Monday, September 26, 2016

Pfizer drops plans to split into two companies; Merck's Keytruda gains competitive edge in China; Apple may be developing health software

The FDA approves Amgen's biosimilar version of Humira

The FDA approves Amgen's biosimilar version of Humira

Amgen's drug is set to compete with AbbVie's Humira, which is the second-best selling drug in the U.S. in 2015.

Five things for pharma marketers to know: Friday, September 23, 2016

Five things for pharma marketers to know: Friday, September 23, 2016

Anthem and Cigna accuse each other of violating merger terms; Alzheimer's experimental drug fails late-stage study; study calls for new approach to eradicate global epidemics

Five things for pharma marketers to know: Thursday, September 22, 2016

Five things for pharma marketers to know: Thursday, September 22, 2016

Mylan CEO comes under fire at House Committee hearing; Abbott OxyContin reps went to great lengths to sell the pain pill; UnitedHealth drops Lantus

The Michael J. Fox Foundation uses Facebook to recruit Ashkenazi Jews for Parkinson's study

The Michael J. Fox Foundation uses Facebook to recruit Ashkenazi Jews for Parkinson's study

The organization said it used Facebook to identify participants for a study designed to identify biomarkers associated with Parkinson's disease.

McCann Health forms new global consultancy

McCann Health forms new global consultancy

The consultancy includes Double Helix, which was acquired by McCann in 2012.

Five things for pharma marketers to know: Wednesday, September 21, 2016

Five things for pharma marketers to know: Wednesday, September 21, 2016

Drugmakers to remove incentives for sales reps marketing antibiotics; Mylan CEO defends EpiPen pricing; fitness trackers don't help people lose weight

Agency Spotlight


OPINION

Email Newsletters